Angioedema without urticaria in childhood. 2013

Hacer I Ertoy Karagol, and Ozlem Yilmaz, and Arzu Bakirtas, and Erdem Topal, and Mehmet S Demirsoy, and Ipek Turktas
Department of Pediatric Allergy and Asthma, Gazi University School of Medicine, Ankara, Turkey.

BACKGROUND There has been no separate study investigating angioedema without urticaria (Aw/oU) exclusively in children so far. The purpose of this study was to investigate the frequency, clinical presentation, etiology, management and follow-up of Aw/oU in children. METHODS This is a prospective study that included all consecutive patients with a history of Aw/oU referred to our clinic between January 2011 and May 2012. A standard diagnostic and therapeutic algorithm was applied to all patients. RESULTS The frequency of Aw/oU was found to be 1.6% during the study period. An etiological factor could be found in only 45 patients (49%). The causes of Aw/oU were infection (21%), allergy (14%), thyroid autoimmunity (TA)-related (8%) and nonsteroid anti-inflammatory drug hypersensitivity (6%), and idiopathic angioedema (51%). There was no hereditary type I, II or acquired type of angioedema or rare syndromes associated with Aw/oU. The median follow-up was 16 months (range: 12-30 months). Antihistamine prophylaxis was initiated at therapeutic doses in 20 patients with frequently recurrent angioedema due to idiopathic and euthyroid TA-related Aw/oU for 3 months. These patients responded to antihistamine prophylaxis for 3 months. Four patients relapsed after cessation of prophylaxis at the end of 3 months. Antihistamine prophylaxis was prolonged to 6 months in three patients and to 9 months in one patient. CONCLUSIONS Angioedema without urticaria in children is a rare condition and no etiology can be identified in half of them. Antihistamine treatment alone is sufficient, and prognosis is good in recurrent non hereditary cases in a short-term follow-up period.

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D007223 Infant A child between 1 and 23 months of age. Infants
D007239 Infections Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases. Infection,Infection and Infestation,Infections and Infestations,Infestation and Infection,Infestations and Infections
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females

Related Publications

Hacer I Ertoy Karagol, and Ozlem Yilmaz, and Arzu Bakirtas, and Erdem Topal, and Mehmet S Demirsoy, and Ipek Turktas
January 2001, Drug safety,
Hacer I Ertoy Karagol, and Ozlem Yilmaz, and Arzu Bakirtas, and Erdem Topal, and Mehmet S Demirsoy, and Ipek Turktas
August 2008, Current opinion in pediatrics,
Hacer I Ertoy Karagol, and Ozlem Yilmaz, and Arzu Bakirtas, and Erdem Topal, and Mehmet S Demirsoy, and Ipek Turktas
September 2017, Acta dermatovenerologica Alpina, Pannonica, et Adriatica,
Hacer I Ertoy Karagol, and Ozlem Yilmaz, and Arzu Bakirtas, and Erdem Topal, and Mehmet S Demirsoy, and Ipek Turktas
October 2006, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
Hacer I Ertoy Karagol, and Ozlem Yilmaz, and Arzu Bakirtas, and Erdem Topal, and Mehmet S Demirsoy, and Ipek Turktas
January 2023, Praxis,
Hacer I Ertoy Karagol, and Ozlem Yilmaz, and Arzu Bakirtas, and Erdem Topal, and Mehmet S Demirsoy, and Ipek Turktas
January 2011, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti,
Hacer I Ertoy Karagol, and Ozlem Yilmaz, and Arzu Bakirtas, and Erdem Topal, and Mehmet S Demirsoy, and Ipek Turktas
June 2024, Drug and therapeutics bulletin,
Hacer I Ertoy Karagol, and Ozlem Yilmaz, and Arzu Bakirtas, and Erdem Topal, and Mehmet S Demirsoy, and Ipek Turktas
September 2023, BMJ case reports,
Hacer I Ertoy Karagol, and Ozlem Yilmaz, and Arzu Bakirtas, and Erdem Topal, and Mehmet S Demirsoy, and Ipek Turktas
December 2014, Annals of medicine,
Hacer I Ertoy Karagol, and Ozlem Yilmaz, and Arzu Bakirtas, and Erdem Topal, and Mehmet S Demirsoy, and Ipek Turktas
December 2022, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!